VERIGRAFT
2 known investors
VERIGRAFT develops technology that modifies donated tissue so it resembles a patient's own tissue, aiming to eliminate immune rejection in transplantation and reduce the need for lifelong immunosuppressants. The company targets patients requiring tissue or organ transplants and addresses currently incurable diseases.
Founders & leadership
PB
Petter BjörquistPhD, Chief Executive Officer
Investors · 2
Frequently asked questions
- What does VERIGRAFT do?
- VERIGRAFT develops technology that modifies donated tissue so it resembles a patient's own tissue, aiming to eliminate immune rejection in transplantation and reduce the need for lifelong immunosuppressants. The company targets patients requiring tissue or organ transplants and addresses currently incurable diseases.
- Who are VERIGRAFT's investors?
- VERIGRAFT's investors include Capital Cell, Scientia Ventures.